Nationwide Multicenter Observational Study of FOLFIRINOX Chemotherapy in 399 Patients With Unresectable or Recurrent Pancreatic Cancer in Japan

MLA

Noritoshi Kobayashi, et al. “Nationwide Multicenter Observational Study of FOLFIRINOX Chemotherapy in 399 Patients With Unresectable or Recurrent Pancreatic Cancer in Japan.” Pancreas, vol. 47, May 2018, pp. 631–36. EBSCOhost, https://doi.org/10.1097/mpa.0000000000001049.

APA

Noritoshi Kobayashi, Masato Ozaka, Akiko Todaka, Shoji Nakamori, Kazuhiro Uesugi, Narikazu Boku, Hideki Ueno, Seigo Yukisawa, Naohiro Okano, Keiko Kamei, Hideyuki Hayashi, Yosuke Horita, Satoshi Kobayashi, Yutaka Yachi, Keita Mori, Akira Fukutomi, Toshiyuki Henmi, Marina Kobayashi, Kentaro Sudo, & Nobumasa Mizuno. (2018). Nationwide Multicenter Observational Study of FOLFIRINOX Chemotherapy in 399 Patients With Unresectable or Recurrent Pancreatic Cancer in Japan. Pancreas, 47, 631–636. https://doi.org/10.1097/mpa.0000000000001049

Chicago

Noritoshi Kobayashi, Masato Ozaka, Akiko Todaka, Shoji Nakamori, Kazuhiro Uesugi, Narikazu Boku, Hideki Ueno, et al. 2018. “Nationwide Multicenter Observational Study of FOLFIRINOX Chemotherapy in 399 Patients With Unresectable or Recurrent Pancreatic Cancer in Japan.” Pancreas 47 (May): 631–36. doi:10.1097/mpa.0000000000001049.